Pergolide for Donkeys: Cushing's Disease Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Pergolide is a dopamine receptor agonist used to help control signs of pituitary pars intermedia dysfunction (PPID), often called equine Cushing's disease. In the United States, pergolide tablets are FDA-approved for horses, and vets may also use them extra-label in donkeys when the expected benefit outweighs the risk. That matters because donkeys are equids, but they are not small horses. Their body size, feeding habits, and disease presentation can differ, so your vet should guide every treatment decision.

Pergolide does not cure PPID. Instead, it helps reduce abnormal hormone signaling from the pituitary gland so many affected donkeys feel better and have fewer complications over time. Depending on the case, treatment goals may include improving hair coat changes, energy level, topline muscle, drinking and urination patterns, and lowering the risk of recurrent laminitis.

Most donkeys who need pergolide stay on it long term, with periodic rechecks and dose adjustments. Your vet may pair the medication with hoof care, diet changes, dental care, and blood testing because PPID management usually works best as a full plan rather than a pill alone.

Pergolide is used primarily for PPID in donkeys. Vets consider it when a donkey has compatible signs such as delayed shedding, a long or curly hair coat, muscle wasting, lethargy, abnormal sweating, increased drinking or urination, repeated infections, or laminitis. Some donkeys show only subtle changes at first, so your vet may recommend testing even before the disease looks advanced.

In practice, pergolide is used to control clinical signs, not to make a lab number look perfect on its own. Your vet may monitor response with a combination of physical changes, body condition, hoof comfort, and endocrine testing such as ACTH, interpreted with seasonal reference ranges. Donkeys with PPID may also have other problems at the same time, including insulin dysregulation or chronic hoof disease, so treatment often needs to be individualized.

Because published donkey-specific drug data are limited, many vets start from equine PPID guidance and then tailor the plan to the individual donkey. That is one reason follow-up matters so much. A dose that helps one donkey may be too low, too high, or poorly tolerated in another.

Pergolide dosing for donkeys should be set by your vet. In horses, labeled pergolide products are started at 2 mcg/kg by mouth once daily, and the dose may be adjusted to effect up to 4 mcg/kg once daily. Because donkey use is extra-label and donkey-specific studies are limited, many vets use this equine framework as a starting point, then adjust based on body weight, clinical response, ACTH results, appetite, and any side effects.

For example, a 180 kg donkey would have a horse-equivalent starting dose of about 0.36 mg once daily, while a 250 kg donkey would be about 0.5 mg once daily. Since tablets are commonly 1 mg and scored, your vet may round to the nearest practical amount. Some clinicians introduce pergolide gradually over several days if a donkey is sensitive to appetite or behavior changes. Do not change the dose, stop the medication, or split tablets differently without checking with your vet first.

Monitoring is part of dosing. Your vet may recommend a recheck in about 4 to 6 weeks after starting or changing the dose, then repeat testing and clinical review every few months until the donkey is stable. Fall can be especially important for monitoring because ACTH values rise seasonally in equids, and some animals need dose adjustments during that period.

The most common side effect reported with pergolide in equids is loss of appetite, especially early in treatment. Some animals also seem quieter than usual, less interested in feed, or mildly lethargic for a short period after starting the medication or after a dose increase. Horse resources sometimes call this the "pergolide veil." In many cases, these effects are mild and improve after the body adjusts, but your vet should still know if they happen.

Other possible side effects include weight loss, low energy, and behavior changes. Less commonly, overdose or marked intolerance may cause digestive upset, incoordination, or more serious neurologic signs. If your donkey stops eating, seems weak, develops worsening laminitis pain, or acts dramatically different, contact your vet promptly.

Human safety matters too. Pergolide tablets should not be crushed because that can increase human exposure. People who have reacted to ergot drugs should not handle the medication, and pregnant or lactating people should wear gloves when administering it. Keep tablets away from dogs, cats, and other animals, since accidental ingestion can cause adverse effects.

Pergolide can interact with other drugs that affect dopamine signaling. In general, dopamine antagonists may reduce pergolide's effect, while other dopamine-active drugs may change how a donkey responds. This is especially relevant if your donkey is receiving medications for reproductive management, gastrointestinal motility, or other less common conditions.

Your vet should also review any history of sensitivity to ergot derivatives, because pergolide is contraindicated in horses with hypersensitivity to pergolide mesylate or related ergot compounds. Donkeys with multiple medical problems may need a more cautious plan, especially if appetite is already poor or if there is active laminitis, weight loss, or another endocrine disorder.

Before starting pergolide, give your vet a full list of everything your donkey receives, including prescription drugs, compounded medications, supplements, hoof products given by mouth, and herbal products. Even when a formal interaction has not been well studied in donkeys, that information helps your vet choose the safest monitoring plan.